UT Health San Antonio-led research discovers a way to slow or block recurrence of glioblastoma
Peer-Reviewed Publication
Updates every hour. Last Updated: 27-Jul-2025 04:11 ET (27-Jul-2025 08:11 GMT/UTC)
Popular prescription weight-loss drugs called GLP-1 receptor agonists are now frequently used by type 1 diabetes patients, despite limited data on the drugs’ safety and effectiveness in this patient population, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
The current capabilities of large language models already qualify them to advise students on medical ethics